Free Cash Flow
Cash generated after capital expenditures.
Latest Free Cash Flow: $3.56B (2026Q1); +154.6% YoY; +9.5% CAGR since 2013Q1 (13y).
Chart and table show the latest 24 of 53 quarters.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly Free Cash Flow Data
Chart and table show the latest 24 of 53 quarters.
| Period | Value |
|---|---|
| 2020Q2 | $2.91B |
| 2020Q3 | $5.61B |
| 2020Q4 | $4.58B |
| 2021Q1 | $4.69B |
| 2021Q2 | $4.70B |
| 2021Q3 | $7.72B |
| 2021Q4 | $4.89B |
| 2022Q1 | $4.75B |
| 2022Q2 | $4.86B |
| 2022Q3 | $7.42B |
| 2022Q4 | $7.21B |
| 2023Q1 | $4.02B |
| 2023Q2 | $6.14B |
| 2023Q3 | $7.36B |
| 2023Q4 | $4.55B |
| 2024Q1 | $3.85B |
| 2024Q2 | $2.03B |
| 2024Q3 | $5.20B |
| 2024Q4 | $6.76B |
| 2025Q1 | $1.40B |
| 2025Q2 | $4.88B |
| 2025Q3 | $6.64B |
| 2025Q4 | $4.89B |
| 2026Q1 | $3.56B |
Healthcare Comparison
1 / 3
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 8